Cargando…
Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients
Autores principales: | Levy, Y, Thiébaut, R, Montes, M, Lacabaratz, C, Sloan, L, Perusat, S, Harrod, C, Boucherie, C, Zurawski, S, Richert, L, Chêne, G, Banchereau, J, Palucka, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441715/ http://dx.doi.org/10.1186/1742-4690-9-S2-P328 |
Ejemplares similares
-
P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial
por: Banchereau, J, et al.
Publicado: (2009) -
P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens
por: Cobb, AJ, et al.
Publicado: (2009) -
Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination
por: Surenaud, Mathieu, et al.
Publicado: (2019) -
Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
por: Thiébaut, Rodolphe, et al.
Publicado: (2019) -
Decreased HIV-Specific T-Regulatory Responses Are Associated with Effective DC-Vaccine Induced Immunity
por: Brezar, Vedran, et al.
Publicado: (2015)